Literature DB >> 26145478

Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9.

Yuejun Chen1, Jingyuan Cao2, Man Xiong3, Andrew J Petersen2, Yi Dong2, Yunlong Tao2, Cindy Tzu-Ling Huang2, Zhongwei Du2, Su-Chun Zhang4.   

Abstract

Precise temporal control of gene expression or deletion is critical for elucidating gene function in biological systems. However, the establishment of human pluripotent stem cell (hPSC) lines with inducible gene knockout (iKO) remains challenging. We explored building iKO hPSC lines by combining CRISPR/Cas9-mediated genome editing with the Flp/FRT and Cre/LoxP system. We found that "dual-sgRNA targeting" is essential for biallelic knockin of FRT sequences to flank the exon. We further developed a strategy to simultaneously insert an activity-controllable recombinase-expressing cassette and remove the drug-resistance gene, thus speeding up the generation of iKO hPSC lines. This two-step strategy was used to establish human embryonic stem cell (hESC) and induced pluripotent stem cell (iPSC) lines with iKO of SOX2, PAX6, OTX2, and AGO2, genes that exhibit diverse structural layout and temporal expression patterns. The availability of iKO hPSC lines will substantially transform the way we examine gene function in human cells.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26145478      PMCID: PMC4530040          DOI: 10.1016/j.stem.2015.06.001

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  52 in total

Review 1.  Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice.

Authors:  Catherine S Branda; Susan M Dymecki
Journal:  Dev Cell       Date:  2004-01       Impact factor: 12.270

2.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

Review 3.  Concise review: Human cell engineering: cellular reprogramming and genome editing.

Authors:  Prashant Mali; Linzhao Cheng
Journal:  Stem Cells       Date:  2012-01       Impact factor: 6.277

4.  An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells.

Authors:  Federico González; Zengrong Zhu; Zhong-Dong Shi; Katherine Lelli; Nipun Verma; Qing V Li; Danwei Huangfu
Journal:  Cell Stem Cell       Date:  2014-06-12       Impact factor: 24.633

5.  Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs.

Authors:  Cory Smith; Athurva Gore; Wei Yan; Leire Abalde-Atristain; Zhe Li; Chaoxia He; Ying Wang; Robert A Brodsky; Kun Zhang; Linzhao Cheng; Zhaohui Ye
Journal:  Cell Stem Cell       Date:  2014-07-03       Impact factor: 24.633

6.  Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing.

Authors:  Adrian Veres; Bridget S Gosis; Qiurong Ding; Ryan Collins; Ashok Ragavendran; Harrison Brand; Serkan Erdin; Chad A Cowan; Michael E Talkowski; Kiran Musunuru
Journal:  Cell Stem Cell       Date:  2014-07-03       Impact factor: 24.633

7.  A simple and efficient system for regulating gene expression in human pluripotent stem cells and derivatives.

Authors:  Kun Qian; Cindy Tzu-Ling Huang; CindyTzu-Ling Huang; Hong Chen; Lisle W Blackbourn; Yuejun Chen; Jingyuan Cao; Lin Yao; Cornall Sauvey; Zhongwei Du; Su-Chun Zhang
Journal:  Stem Cells       Date:  2014-05       Impact factor: 6.277

8.  Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons.

Authors:  Hong Chen; Kun Qian; Zhongwei Du; Jingyuan Cao; Andrew Petersen; Huisheng Liu; Lisle W Blackbourn; CindyTzu-Ling Huang; Anthony Errigo; Yingnan Yin; Jianfeng Lu; Melvin Ayala; Su-Chun Zhang
Journal:  Cell Stem Cell       Date:  2014-04-03       Impact factor: 24.633

9.  Genetic engineering of human pluripotent cells using TALE nucleases.

Authors:  Dirk Hockemeyer; Haoyi Wang; Samira Kiani; Christine S Lai; Qing Gao; John P Cassady; Gregory J Cost; Lei Zhang; Yolanda Santiago; Jeffrey C Miller; Bryan Zeitler; Jennifer M Cherone; Xiangdong Meng; Sarah J Hinkley; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Rudolf Jaenisch
Journal:  Nat Biotechnol       Date:  2011-07-07       Impact factor: 54.908

10.  The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli.

Authors:  Rimantas Sapranauskas; Giedrius Gasiunas; Christophe Fremaux; Rodolphe Barrangou; Philippe Horvath; Virginijus Siksnys
Journal:  Nucleic Acids Res       Date:  2011-08-03       Impact factor: 16.971

View more
  71 in total

Review 1.  Genome editing: a robust technology for human stem cells.

Authors:  Arun Pandian Chandrasekaran; Minjung Song; Suresh Ramakrishna
Journal:  Cell Mol Life Sci       Date:  2017-04-12       Impact factor: 9.261

2.  Simultaneous reprogramming and gene editing of human fibroblasts.

Authors:  Sara E Howden; James A Thomson; Melissa H Little
Journal:  Nat Protoc       Date:  2018-04-05       Impact factor: 13.491

Review 3.  To CRISPR and beyond: the evolution of genome editing in stem cells.

Authors:  Kuang-Yui Chen; Paul S Knoepfler
Journal:  Regen Med       Date:  2016-12-01       Impact factor: 3.806

4.  Patient-derived induced pluripotent stem cells in cancer research and precision oncology.

Authors:  Eirini P Papapetrou
Journal:  Nat Med       Date:  2016-12-06       Impact factor: 53.440

Review 5.  From Reductionism to Holism: Toward a More Complete View of Development Through Genome Engineering.

Authors:  Rebecca K Delker; Richard S Mann
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 6.  Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery.

Authors:  Alec S T Smith; Jennifer Davis; Gabsang Lee; David L Mack; Deok-Ho Kim
Journal:  Drug Discov Today       Date:  2016-04-22       Impact factor: 7.851

Review 7.  Induced Pluripotent Stem Cells Meet Genome Editing.

Authors:  Dirk Hockemeyer; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2016-05-05       Impact factor: 24.633

Review 8.  The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models.

Authors:  Ming Shao; Tian-Rui Xu; Ce-Shi Chen
Journal:  Dongwuxue Yanjiu       Date:  2016-07-18

9.  Pathogenic Tau Impairs Axon Initial Segment Plasticity and Excitability Homeostasis.

Authors:  Peter Dongmin Sohn; Cindy Tzu-Ling Huang; Rui Yan; Li Fan; Tara E Tracy; Carolina M Camargo; Kelly M Montgomery; Taylor Arhar; Sue-Ann Mok; Rebecca Freilich; Justin Baik; Manni He; Shiaoching Gong; Erik D Roberson; Celeste M Karch; Jason E Gestwicki; Ke Xu; Kenneth S Kosik; Li Gan
Journal:  Neuron       Date:  2019-09-18       Impact factor: 17.173

10.  Chemical Control of Grafted Human PSC-Derived Neurons in a Mouse Model of Parkinson's Disease.

Authors:  Yuejun Chen; Man Xiong; Yi Dong; Alexander Haberman; Jingyuan Cao; Huisheng Liu; Wenhao Zhou; Su-Chun Zhang
Journal:  Cell Stem Cell       Date:  2016-04-28       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.